ICU
SeaStar Medical Holding Corporation
NASDAQ · Healthcare · Biotechnology · US
$2.98
+2.40%Margins
Gross margin
92.6%
EBITDA margin
-797.5%
EBIT margin
-816.6%
Net margin
-795.5%
FCF margin
-799.4%
-317.2%
Return on equity
-157.6%
Return on assets
-325.6%
Return on invested capital
0.17x
Asset turnover
-$13.7M
Cash from operations
$1.58
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026